Santen Worldwide. Santen Pharmaceutical offers innovative ophthalmic products and a clear vision for life to people throughout the world.
Employees: 1001-5000
Founded date: 1890
Investors 1
Date | Name | Website |
- | Auriga Par... | auriga.vc |
Mentions in press and media 9
Date | Title | Description | Source |
25.03.2024 | Santen Pharmaceutical Co., Ltd. Notice regarding change of r... | Santen Pharmaceutical Co., Ltd. Notice regarding change of representative director …… On March 25, 2... | re-how.net... |
27.12.2022 | Prevent Blindness Invites Patients and Caregivers to Join Th... | Prevent Blindness invites public to join "The Glaucoma Community" as part of January's Nat... | prweb.com/... |
08.11.2021 | Santen Reports the 2nd Quarter Fiscal 2021 Consolidated Perf... | Summary of Consolidated Financial Results for the Six Months Ended September 30, 2021 (IFRS) Listed ... | marketscre... |
04.02.2020 | Verily Launches Joint Venture to Develop & Commercialize... | – Alphabet company Verily and Santen Pharmaceutical launch joint venture focused on developing and c... | hitconsult... |
09.11.2011 | FDA says no to Merck oral contraceptive, eye treatment drugs... | The company is also discontinuing the clinical development program for MK-0431C, a diabetes treatmen... | medcitynew... |
30.03.2011 | Dry eye drug from Inspire gets patent extension in Japan | Diquafosol tetrasodium, marketed as Diquas, was launched in December by Japan-based drug partner San... | medcitynew... |
- | Santen and RVL Pharmaceuticals, Inc., an Osmotica Company, E... | OSAKA, Japan and BRIDGEWATER, N.J., July 28, 2020 (GLOBE NEWSWIRE) — Santen Pharmaceutical Co., Ltd ... | avistacap.... |
- | Dry eye drug from Inspire gets patent extension in Japan | Two dry eye therapy patents owned by Inspire Pharmaceuticals (NASDAQ:ISPH) have received extensions ... | medcitynew... |
- | FDA says no to Merck oral contraceptive, eye treatment drugs... | Merck (NYSE: MRK) has received complete letters from the US Food and Drug Administration for an oral... | medcitynew... |